Street Signs


  • Michael Morrissey, Exelixis president & CEO, provides insight on clinical research of prostate cancer and its cancer drug Cometriq.

  • FUBU founder on 'Shark Tank' success  Tuesday, 14 Jan 2014 | 2:53 PM ET

    "Shark Tank's" Daymond John discusses which participants are successful on "Shark Tank," and the current environment for selling some of these successful businesses.

  • Rising stars in social media  Tuesday, 14 Jan 2014 | 2:41 PM ET

    CNBC's Julia Boorstin reports on 3 rising social startups, including "Jelly," which enables users to ask questions to their social network through pictures.

  • Bentley Continental GT V8 available in '14  Monday, 13 Jan 2014 | 2:54 PM ET

    CNBC's Phil LeBeau speaks with Bentley Motors Chief Operating Officer Christophe Georges about the launch of the Continental GT V8.

  • HSN Inc. CEO: Customer trust a priority  Monday, 13 Jan 2014 | 2:48 PM ET

    What can retailers do to protect customers' data? HSN Inc. CEO Mindy Grossman discusses how her company has invested in data security.

  • HSN Inc. CEO: Mobile was 12% of entire business  Monday, 13 Jan 2014 | 2:47 PM ET

    HSN Inc. CEO Mindy Grossman says her company invested in mobile, and remained focused on proprietary product and value and the customer experience. "It's about generosity; what are you doing for your customer not just because you want to sell them something," she says.

  • Alexandria CEO: Real estate a long-term play  Monday, 13 Jan 2014 | 2:38 PM ET

    Alexandria Real Estate Equities founder, chairman and CEO Joel Marcus discuss its firm's success, and how rising yields impact its dividend.

  • Alexandria CEO: Top tenants looking for more space  Monday, 13 Jan 2014 | 2:36 PM ET

    Alexandria Real Estate Equities founder, chairman and CEO Joel Marcus discuss real estate demand in the biotech industry.

  • Health care ripe for revolution?  Monday, 13 Jan 2014 | 2:34 PM ET

    CNBC's Brian Sullivan and Josh Lipton discuss venture capital investments in health care.

  • Perrigo CEO: Elan purchase lowers tax rate  Monday, 13 Jan 2014 | 2:24 PM ET

    Perrigo CEO Joseph Papa discusses how its new headquarters in Ireland will impact its tax structure, and whether the company will add a dividend.

  • Perrigo CEO: Got to get our name out  Monday, 13 Jan 2014 | 2:24 PM ET

    Perrigo CEO Joseph Papa provides insight on the current flu season, and how it plans on getting its name better known.

  • Biogen CEO: More products, company is focused  Monday, 13 Jan 2014 | 2:15 PM ET

    Biogen Idec CEO George Scangos discusses the busy year ahead for the company, including the EU launch of Tecfidera and when a dividend will be offered.

  • Roche now world leader in cancer treatment: Pro  Friday, 10 Jan 2014 | 2:45 PM ET

    The outlook for biotech is "wonderful," explains Sam Isaly, Orbimed Advisors managing partner.

  • Agios's new approach to cancer  Monday, 13 Jan 2014 | 11:00 AM ET

    Agios CEO David Schenkein on a new approach to cancer, and the outlook for product approval, from the JPMorgan Health Care Conference in San Francisco.

  • Accuray CEO: History of innovation  Monday, 13 Jan 2014 | 10:00 AM ET

    Accuray CEO Joshua Levine talks to CNBC's Brian Sullivan about his company's history of innovation and how it deals with larger competitors.

  • Target: Data breach affected up to 110 million Friday, 10 Jan 2014 | 1:34 PM ET

    Target disclosed that a mass information breach involved data belonging to up to 70 million customers.

  • Nasty correction this summer: Pro  Monday, 13 Jan 2014 | 2:03 PM ET

    Discussing current market action and what it signals about economic growth, with James Paulsen, Wells Capital Management CIO, and Linda Duessel, Federated Investors.

  • Digging into the financials of various retailers, including Five Below and Sears, with Jan Kniffen, CEO of Worldwide Enterprises, and Herb Greenberg of TheStreet.com.

  • Genzyme's investment in Alnylam  Monday, 13 Jan 2014 | 11:00 AM ET

    Alnylam CEO John Maraganore talks to Brian Sullivan about today's big announcement of a huge investment in the company by Genzyme. From the JPM Health Care Conference in San Francisco.

  • Esbriet's chance of approval: InterMune CEO  Monday, 13 Jan 2014 | 11:00 AM ET

    Brian asks InterMune Chairman, President and CEO Dan Welch for an update on its drug Esbriet, and chances for U.S. approval.

About Street Signs

  • "Street Signs" airs live 2-3pm ET, Monday-Friday from CNBC Global Headquarters. The show is must see TV for savvy investors looking to capitalize on opportunities beyond the headlines and the herd mentality. Brian Sullivan and Amanda Drury read the signs on Wall Street everyday for the under-the-radar stocks and market trends to make you money.

Contact Street Signs

  • Showtimes

    United States
    Monday - Friday 2:00P ET
    Monday - Friday 20:00 CET
    Tuesday - Saturday 02:00 SIN/HK
    Tuesday - Saturday 04:00 SYD
    New Zealand
    Tuesday - Saturday 06:00 NZ


  • "Street Signs" Co-Anchor

  • Co-anchor of CNBC's "Street Signs," Amanda Drury is based at the network's global headquarters in Englewood Cliffs, N.J.